- Home
- ARKO vs DCTH Comparison
ARKO vs DCTH Comparison
Compare ARKO & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARKO
- DCTH
- Stock Information
- Founded
- ARKO 1970
- DCTH 1988
- Country
- ARKO United States
- DCTH United States
- Employees
- ARKO N/A
- DCTH N/A
- Industry
- ARKO Oil Refining/Marketing
- DCTH Medical/Dental Instruments
- Sector
- ARKO Energy
- DCTH Health Care
- Exchange
- ARKO Nasdaq
- DCTH Nasdaq
- Market Cap
- ARKO 522.1M
- DCTH 518.0M
- IPO Year
- ARKO N/A
- DCTH N/A
- Fundamental
- Price
- ARKO $4.10
- DCTH $11.63
- Analyst Decision
- ARKO Hold
- DCTH Strong Buy
- Analyst Count
- ARKO 3
- DCTH 4
- Target Price
- ARKO $6.58
- DCTH $22.75
- AVG Volume (30 Days)
- ARKO 707.0K
- DCTH 476.1K
- Earning Date
- ARKO 05-06-2025
- DCTH 05-13-2025
- Dividend Yield
- ARKO 3.02%
- DCTH N/A
- EPS Growth
- ARKO N/A
- DCTH N/A
- EPS
- ARKO 0.13
- DCTH N/A
- Revenue
- ARKO $8,731,962,000.00
- DCTH $37,205,000.00
- Revenue This Year
- ARKO N/A
- DCTH $128.78
- Revenue Next Year
- ARKO N/A
- DCTH $54.07
- P/E Ratio
- ARKO $31.55
- DCTH N/A
- Revenue Growth
- ARKO N/A
- DCTH 1701.69
- 52 Week Low
- ARKO $3.51
- DCTH $4.26
- 52 Week High
- ARKO $7.84
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- ARKO 46.21
- DCTH 44.80
- Support Level
- ARKO $3.92
- DCTH $11.20
- Resistance Level
- ARKO $4.28
- DCTH $11.81
- Average True Range (ATR)
- ARKO 0.27
- DCTH 0.98
- MACD
- ARKO 0.09
- DCTH 0.04
- Stochastic Oscillator
- ARKO 76.62
- DCTH 51.25
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.